Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lineage Cell Therapeutics Inc. Major Shareholding Notification 2022

Mar 29, 2022

6895_rns_2022-03-29_d5603ef1-020f-4ba4-8a99-1c8c101e8332.htm

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Statement of Changes in Beneficial Ownership - Culley Brian M.����� ������ ���� �����- Culley Brian M. false

������' �� ��������� ���� 2 380
.LINEAGE CELL THERAPEUTICS, INC
Corporation no: 876343 10834
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 29/03/2022
www.isa.gov.il www.tase.co.il Reference: 2022-02-037012 Time of broadcast: 09:19 09:19

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onStatement of Changes in Beneficial Ownership - Culley Brian M. ����� ������ ���� �����- Culley Brian M.

0001493152-22-007925_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 22/02/2022
Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502   CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389
E-mail address: [email protected]   Company site: biotimeinc.com
Previous names of reporting entity: .BIOTIME, INC
Name of the Signatory: Gerzi Ilan Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ
Address: Derech Menachem Begin 132 , Tel-Aviv 6702101 Telephone: 03-6073777 Facsimile: 03-6073778 E-mail: [email protected] 1
U.S.A